Jove
Visualize
Contact Us

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Scroll Turbinate Inter-cartilaginous Graft (STIG).

Facial plastic surgery : FPS·2026
Same author

Approaches to Invasive Fungal Diseases in Paediatric Cancer Centres: An Analysis of Current Practices and Challenges in Germany, Austria and Switzerland.

Mycoses·2025
Same author

Quinizarin Gold(I) N-Heterocyclic Carbene Complexes with Synergistic Activity Against Anthracycline-Resistant Leukaemia Cells: Synthesis and Biological Activity Studies.

Chemistry (Weinheim an der Bergstrasse, Germany)·2025
Same author

A New Class of Gold(I) NHC Complexes with Proapoptotic and Resensitizing Properties towards Multidrug Resistant Leukemia Cells Overexpressing BCL-2.

Journal of medicinal chemistry·2024
Same author

(2,6-Dimethylphenyl)arsonic Acid Induces Apoptosis through the Mitochondrial Pathway, Downregulates XIAP, and Overcomes Multidrug Resistance to Cytostatic Drugs in Leukemia and Lymphoma Cells In Vitro.

International journal of molecular sciences·2024
Same author

Synthesis, characterization, and biomedical evaluation of ethylene-bridged tetra-NHC Pd(ii), Pt(ii) and Au(iii) complexes, with apoptosis-inducing properties in cisplatin-resistant neuroblastoma cells.

RSC advances·2024
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Synthesis of demethylxanthohumol, a new potent apoptosis-inducing agent from hops.

Reinhard A Diller1, Herbert M Riepl, Oliver Rose

  • 1Institute of Technology for Biogenic Resources, Technical University of Munich, Petersgasse 18, D-94315 Straubing.

Chemistry & Biodiversity
|December 29, 2006
PubMed
Summary

Researchers synthesized demethylxanthohumol, a hops-derived prenylchalcone, which showed significant antiproliferative effects. This compound also induced apoptosis in cancer cell lines, including Burkitt lymphoma and acute lymphoblastic leukemia.

More Related Videos

Synthesis of an In vivo MRI-detectable Apoptosis Probe
06:58

Synthesis of an In vivo MRI-detectable Apoptosis Probe

Published on: July 31, 2012

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Related Experiment Videos

Last Updated: Jun 25, 2026

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

Synthesis of an In vivo MRI-detectable Apoptosis Probe
06:58

Synthesis of an In vivo MRI-detectable Apoptosis Probe

Published on: July 31, 2012

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources
10:24

A Fluorescence-based Protocol for Preliminary Screening of Protein Synthesis Inhibitors from Natural Sources

Published on: January 27, 2026

Area of Science:

  • Natural Product Chemistry
  • Medicinal Chemistry
  • Cancer Biology

Background:

  • Xanthohumol, a prenylchalcone from hops (Humulus lupulus), possesses various biological activities.
  • Derivatives of xanthohumol are being explored for enhanced therapeutic potential.
  • The 6'-O-methyl group in xanthohumol can influence its properties.

Purpose of the Study:

  • To synthesize demethylxanthohumol (4), a novel xanthohumol derivative lacking the 6'-O-methyl group.
  • To evaluate the antiproliferative and apoptotic effects of demethylxanthohumol (4) in cancer cell lines.

Main Methods:

  • Synthesis of demethylxanthohumol (4) via aldol condensation of MOM-protected acetophenone (2) and MOM-protected benzaldehyde (3).
  • Starting material: Commercially available phloracetophenone (1-(2,4,6-trihydroxyphenyl)ethanone).
  • Assessment of antiproliferative activity and apoptosis induction in BJAB cells and primary lymphoblasts from childhood acute lymphoblastic leukemia (ALL).

Main Results:

  • Successful synthesis of demethylxanthohumol (4).
  • Demethylxanthohumol (4) demonstrated significant antiproliferative properties.
  • Demethylxanthohumol (4) induced apoptosis through the mitochondrial pathway in BJAB cells and ALL lymphoblasts.

Conclusions:

  • Demethylxanthohumol (4) is a potent antiproliferative agent.
  • The compound effectively induces apoptosis in B-cell lymphoma and leukemia cell lines.
  • This derivative represents a promising lead compound for cancer therapy development.